These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4101095)

  • 21. New orally effective chromosome derivatives for the treatment of asthma.
    Augstein J; Cairns H; Hunter D; Lee TB; Suschitzky J; Altounyan RE; Jackson DM; Mann J; Orr TS; Sheard P
    Agents Actions; 1977 Oct; 7(4):443-5. PubMed ID: 930755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.
    Cox JS
    Br J Dis Chest; 1971 Oct; 65(4):189-204. PubMed ID: 4400180
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA; Ross JW; Smith H
    Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of IgE mediated responses as a pharmacologic test system. The effect of disodium cromoglycate in respiratory and cutaneous reactions and on the electrocardiograms of rhesus monkeys.
    Patterson R; Talbot CH; Brandfonbrener M
    Int Arch Allergy Appl Immunol; 1971; 41(4):592-603. PubMed ID: 5001999
    [No Abstract]   [Full Text] [Related]  

  • 25. Delayed hypersensitivity to insulin and its component polypeptide chains.
    Clark C; Munoz J
    J Immunol; 1970 Sep; 105(3):574-83. PubMed ID: 4195496
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentiation of rat reaginic (IgE) antibody by helminth infection. Simultaneous potentiation of separate reagins.
    Jarrett EE; Stewart DC
    Immunology; 1972 Nov; 23(5):749-55. PubMed ID: 4344216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disodium cromoglycate (Intal).
    Cox JS; Beach JE; Blair AM; Clarke AJ; King J; Lee TB; Loveday DE; Moss GF; Orr TS; Ritchie JT; Sheard P
    Adv Drug Res; 1970; 5():115-96. PubMed ID: 4099491
    [No Abstract]   [Full Text] [Related]  

  • 28. What potential do heterobivalent inhibitors have for the treatment of severe allergic reactions?
    Handlogten MW; Serezani AP; Kaplan MH; Bilgicer B
    Immunotherapy; 2014; 6(3):223-5. PubMed ID: 24762067
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacologic dissociation of immunologic release of histamine and slow reacting substance of anaphylaxis in rats.
    Orange RP; Austen KF
    Proc Soc Exp Biol Med; 1968 Dec; 129(3):836-41. PubMed ID: 4177758
    [No Abstract]   [Full Text] [Related]  

  • 30. [The search for new antiallergy compounds among a number of coumarin derivatives and the study of their mechanisms of action].
    Saraf AS; Simonian AV; Oganesian ET
    Eksp Klin Farmakol; 1993; 56(2):47-50. PubMed ID: 7688624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vitro model of canine immediate-type hypersensitivity reactions.
    Krell RD; Chakrin LW
    Int Arch Allergy Appl Immunol; 1976; 51(6):641-55. PubMed ID: 63451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of mouse reaginic antibodies in the rat: passive cutaneous anaphylaxis and in vitro passive histamine release.
    Bach MK; Brashler JR
    Immunol Commun; 1973; 2(1):85-91. PubMed ID: 4139107
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions.
    Lopez M; Bloch KJ
    J Immunol; 1969 Dec; 103(6):1428-30. PubMed ID: 5361571
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of disodium cromoglycate in animal-sensitive asthmatics.
    Wyse DM
    Can Med Assoc J; 1971 Apr; 104(7):615. PubMed ID: 4994476
    [No Abstract]   [Full Text] [Related]  

  • 35. Disodium cromoglycate, an inhibitor of mas cell degranulation and histamine release induced by phospholipase A.
    Orr TS; Cox JS
    Nature; 1969 Jul; 223(5202):197-8. PubMed ID: 4183038
    [No Abstract]   [Full Text] [Related]  

  • 36. The mast cell and disodium cromoglycate in immediate type reactions.
    Orr TS
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):300-7. PubMed ID: 4142838
    [No Abstract]   [Full Text] [Related]  

  • 37. Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate.
    Goose J; Blair AM
    Immunology; 1969 Jun; 16(6):749-60. PubMed ID: 4306785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced modulation of the immunologic release of histamine and slow reacting substance of anaphylaxis.
    Orange RP; Austen KF
    Int Arch Allergy Appl Immunol; 1971; 41(1):79-85. PubMed ID: 4104672
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of allergic reactions with monoclonal antibody to the high affinity IgE receptor.
    Kitani S; Kraft D; Fischler C; Mergenhagen SE; Siraganian RP
    J Immunol; 1988 Apr; 140(8):2585-8. PubMed ID: 2451693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
    Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
    J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.